Presentation is loading. Please wait.

Presentation is loading. Please wait.

A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD,

Similar presentations


Presentation on theme: "A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD,"— Presentation transcript:

1 A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD, Peter N. Black, FRACP, Thorsten V. Stanley, FRCP, Edwin Mitchell, FRACP, DSc, Penny Fitzharris, FRACP, Gerald W. Tannock, PhD, Gordon Purdie, BSc, Julian Crane, FRACP  Journal of Allergy and Clinical Immunology  Volume 122, Issue 4, Pages (October 2008) DOI: /j.jaci Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Diagram showing the flow of participants in the placebo, L rhamnosus HN001, and B animalis subsp lactis HN019 groups. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Kaplan-Meier plot showing the 2-year cumulative prevalence of eczema in infants taking placebo, L rhamnosus HN001, or B animalis subsp lactis HN019. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Kaplan-Meier plot showing the 2-year cumulative prevalence of SCORAD ≥10 in infants taking placebo, L rhamnosus HN001, or B animalis subsp lactis HN019. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 A, For each infant group (administered B animalis subsp lactis HN019, L rhamnosus HN001, or placebo), the percentage in which B animalis subsp lactis was detected at each time point (in months). B, For each infant group (administered B animalis subsp lactis HN019, L rhamnosus HN001, or placebo), the percentage in which L rhamnosus was detected at each time point (in months). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD,"

Similar presentations


Ads by Google